An interventional study of ULRT + tSCS + conventional occupational therapy and ULRT + conventional occupational therapy in Spinal Cord Injuries, sponsored by National University Hospital, Singapore. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-02-25.
Sponsored by National University Hospital, Singapore · Not applicable, Interventional, and Treatment
This study is aimed to evaluate whether transcutaneous spinal cord stimulation (tSCS) can augment upper limb robotic training (ULRT) to improve functional mobility in participants with chronic spinal cord injuries. It also evaluates the impact of the tSCS+ULRT on health-related quality of life (HRQOL), compared to ULRT alone.
This is a prospective single-arm crossover study in participants with incomplete chronic traumatic spinal cord injury. 6 to 8 subjects with C2-8 level injuries will be recruited. The intervention includes Phase 1 of training which consists of 16 sessions of ULRT + conventional occupational therapy in 8-10 weeks, and Phase 2 of training which consists of 16 sessions of ULRT training + tSCS + conventional occupational therapy in 8-10 weeks.
Outcome measures including mobility function assessment and neuromuscular assessment will be collected at Baseline, Post-Phase 1, Post-Phase 2, and 4 weeks Follow-up. A satisfaction survey on the intervention "ULRT training + tSCS + conventional physiotherapy" will be performed at end of the study.
This study is aimed to evaluate whether transcutaneous spinal cord stimulation (tSCS) can augment upper limb robotic training (ULRT) to improve functional mobility in participants with chronic paraplegia. It also evaluate the impact of the tSCS+ULRT on health-related quality of life (HRQOL), compared to ULRT alone.
This is a prospective single-arm crossover study in participants with incomplete chronic traumatic spinal cord injury. 6 subjects with C2-8 level injuries will be recruited. Once subject is identified to be eligible for the study and is agreeable to participate into the study, he/she will undergo Phase 1 of training which consists of 16 sessions of upper limb robotic training (ULRT) + conventional occupational therapy in 8-10 weeks. After a 1-week washout period, subject will undergo Phase 2 of training which consists of 16 sessions of ULRT training + tSCS + conventional occupational therapy in 8-10 weeks.
This study will use the locally developed H-Man arm rehabilitation robot and Esoglove™ PRO hand rehabilitation system for ULRT. The H-Man robot, a table-top, portable, 2D planar, end-effector with virtual reality feedback is designed to deliver self-paced, repetitive reaching arm movements. The soft robotic glove EsoGlove enables patients to carry out upper-limb rehabilitation with multiple training modes, such as passive training, active-assisted range of motion training, and bilateral training. Participants could choose either H-man or Esoglove, or use both alternatively for ULRT training, according to their functional impairment. ULRT will be paired with functional training during the intervention sessions.
During tSCS, two surface electrodes will be positioned in between the vertebral processes located generally one vertebral segment rostral and one vertebral segment caudal to the site of injury. Reference/Ground electrodes placed over the ASIS. It will be on biphasic mode with an overlap frequency of 10kHz, Burst Frequency of 30Hz, Pulse width of 1ms. Stimulation intensity ranges from 5-100 mA and will be adjusted according to the patient's response. The tSCS stimulation duration for each session will be 45 minutes in conjunction with the RGT training
Outcome measures including mobility function assessment and neuromuscular assessment will be collected at Baseline (within 1 week before the starting of Phase 1 of training), Post-Phase 1 (within 1 week after Phase 1 of training), Post-Phase 2 (within 1 week after Phase 2 of training), and 4 weeks Post Phase 2
A satisfaction survey on the intervention "ULRT training + tSCS + conventional physiotherapy" will be performed at week-18 assessment.
1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.
This study's planned enrollment of 6 is below the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.
Browse Spinal Cord Injuries studies →National University Hospital, Singapore is the lead sponsor of 444 studies on the registry; 96 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
16 sessions of ULRT + conventional occupational therapy in 8-10 weeks
Device: ULRT + conventional occupational therapy
Phase 2: 16 sessions of ULRT training + transcutaneous electrical stimulation (tSCS) + conventional occupational therapy in 8-10 weeks
Device: ULRT + tSCS + conventional occupational therapy
Subject will undergo 16 sessions of Upper limb robotics training (ULRT) + tSCS+ conventional occupational therapy, 2 sessions a week for 8-10 weeks. Participants will use either H-Man arm rehabilitation robot or Esoglove™ PRO hand rehabilitation system, or both according to their functional impairment for ULRT. Participants will undergo conventional occupational therapy as prescribed by the attending occupational therapist based on their assessment. During tSCS, cathodes will be placed on the T11 and L1 spinous process. Reference/Ground electrodes placed over the ASIS. It will be on biphasic mode with a stimulation delivered at 30-50 Hz with a 10-kHz carrier frequency overlay, which consisted of 10 pulses with a 10-kHz frequency and 100-µs pulse width.Stimulation intensity ranges from 5-100 mA and will be adjusted according to the patient's response.The tSCS stimulation duration for each session will be 45 minutes in conjunction with the ULRT training.
Participants will undergo 16 sessions of ULRT + conventional occupational therapy in 8-10 weeks. Participants will use either H-Man arm rehabilitation robot or Esoglove™ PRO hand rehabilitation system, or both according to their functional impairment for ULRT. Participants will undergo conventional occupational therapy as prescribed by the attending occupational therapist based on their assessment.
GRASSP 2
The GRASSP Version 2 is a clinical impairment measure specific to the upper limb for use after tetraplegia. The GRASSP measure sensorimotor and prehension function through three domains; important in describing arm and hand function.
Time frame: Week 0
GRASSP 2
The GRASSP Version 2 is a clinical impairment measure specific to the upper limb for use after tetraplegia. The GRASSP measure sensorimotor and prehension function through three domains; important in describing arm and hand function.
Time frame: Week 8
GRASSP 2
The GRASSP Version 2 is a clinical impairment measure specific to the upper limb for use after tetraplegia. The GRASSP measure sensorimotor and prehension function through three domains; important in describing arm and hand function.
Time frame: Week 16
GRASSP 2
The GRASSP Version 2 is a clinical impairment measure specific to the upper limb for use after tetraplegia. The GRASSP measure sensorimotor and prehension function through three domains; important in describing arm and hand function.
Time frame: Week 20
International standards for Neurological Classification of SCI (ISNCSCI)
The test is to define and describe the extent and severity of a patient's spinal cord injury. The patient's grade is based on how much sensation he or she can feel at multiple points on the body, as well as tests of motor function. The results ranged from A (worst- complete lack of motor and sensory function below the level of injury) to E (best, all neurologic function has returned)
Time frame: Week 0
International standards for Neurological Classification of SCI (ISNCSCI)
The test is to define and describe the extent and severity of a patient's spinal cord injury. The patient's grade is based on how much sensation he or she can feel at multiple points on the body, as well as tests of motor function. The results ranged from A (worst- complete lack of motor and sensory function below the level of injury) to E (best, all neurologic function has returned)
Time frame: Week 8
International standards for Neurological Classification of SCI (ISNCSCI)
The test is to define and describe the extent and severity of a patient's spinal cord injury. The patient's grade is based on how much sensation he or she can feel at multiple points on the body, as well as tests of motor function. The results ranged from A (worst- complete lack of motor and sensory function below the level of injury) to E (best, all neurologic function has returned)
Time frame: Week 16
International standards for Neurological Classification of SCI (ISNCSCI)
The test is to define and describe the extent and severity of a patient's spinal cord injury. The patient's grade is based on how much sensation he or she can feel at multiple points on the body, as well as tests of motor function. The results ranged from A (worst- complete lack of motor and sensory function below the level of injury) to E (best, all neurologic function has returned)
Time frame: Week 20
Central motor conduction time (CMCT)
Measured by transcranial magnetic stimulation (TMS). It is calculated by subtracting the peripheral conduction time (PMCT) from motor evoked potential (MEP) latency elicited by TMS to the motor cortex. Higher results indicates longer central motor conduction time and poor performance.
Time frame: Week 0
Central motor conduction time (CMCT)
Measured by transcranial magnetic stimulation (TMS). It is calculated by subtracting the peripheral conduction time (PMCT) from motor evoked potential (MEP) latency elicited by TMS to the motor cortex. Higher results indicates longer central motor conduction time and poor performance.
Time frame: Week 8
Central motor conduction time (CMCT)
Measured by transcranial magnetic stimulation (TMS). It is calculated by subtracting the peripheral conduction time (PMCT) from motor evoked potential (MEP) latency elicited by TMS to the motor cortex. Higher results indicates longer central motor conduction time and poor performance.
Time frame: Week 16
Central motor conduction time (CMCT)
Measured by transcranial magnetic stimulation (TMS). It is calculated by subtracting the peripheral conduction time (PMCT) from motor evoked potential (MEP) latency elicited by TMS to the motor cortex. Higher results indicates longer central motor conduction time and poor performance.
Time frame: Week 20
Capabilities of Upper Extremity Test (CUE-T)
It is used for assessing functional limitations, assessing upper extremity functions of the subject. A higher score suggests greater upper extremity function.
Time frame: Week 0
Capabilities of Upper Extremity Test (CUE-T)
It is used for assessing functional limitations, assessing upper extremity functions of the subject. A higher score suggests greater upper extremity function.
Time frame: Week 8
Capabilities of Upper Extremity Test (CUE-T)
It is used for assessing functional limitations, assessing upper extremity functions of the subject. A higher score suggests greater upper extremity function.
Time frame: Week 16
Capabilities of Upper Extremity Test (CUE-T)
It is used for assessing functional limitations, assessing upper extremity functions of the subject. A higher score suggests greater upper extremity function.
Time frame: Week 20
Grip, Pinch and Tripod Pinch Strength, measured using Dynamometer and Pinch Gauge
To assess grip and pinch strength, a dynamometer is used for overall grip and a pinch gauge measures different pinch type. Testing involves subject sitting with arm bent at the elbow to 90 degrees and forearm in neutral position. The subject will squeeze the dynamometer and pinch the gauge as hard as possible in a smooth motion. Three trials will be performed, and the average of these recordings is recorded.
Time frame: Week 0
Grip, Pinch and Tripod Pinch Strength, measured using Dynamometer and Pinch Gauge
To assess grip and pinch strength, a dynamometer is used for overall grip and a pinch gauge measures different pinch type. Testing involves subject sitting with arm bent at the elbow to 90 degrees and forearm in neutral position. The subject will squeeze the dynamometer and pinch the gauge as hard as possible in a smooth motion. Three trials will be performed, and the average of these recordings is recorded.
Time frame: Week 8
Grip, Pinch and Tripod Pinch Strength, measured using Dynamometer and Pinch Gauge
To assess grip and pinch strength, a dynamometer is used for overall grip and a pinch gauge measures different pinch type. Testing involves subject sitting with arm bent at the elbow to 90 degrees and forearm in neutral position. The subject will squeeze the dynamometer and pinch the gauge as hard as possible in a smooth motion. Three trials will be performed, and the average of these recordings is recorded.
Time frame: Week 16
Grip, Pinch and Tripod Pinch Strength, measured using Dynamometer and Pinch Gauge
To assess grip and pinch strength, a dynamometer is used for overall grip and a pinch gauge measures different pinch type. Testing involves subject sitting with arm bent at the elbow to 90 degrees and forearm in neutral position. The subject will squeeze the dynamometer and pinch the gauge as hard as possible in a smooth motion. Three trials will be performed, and the average of these recordings is recorded.
Time frame: Weeks 20
Modified Tardieu Scale
Modified Tardieu Scale is to measure if there is spasticity present in a person's muscle and its response to movement. It will be measured for Quadriceps, Hamstrings, Gastrocnemius. A large difference between R1 and R2 suggests a large dynamic component with a greater capacity for change or improvement. A small difference between R1 and R2 suggests a predominantly fixed contracture in the muscle with a poorer capacity for change.
Time frame: Week 0
Modified Tardieu Scale
Modified Tardieu Scale is to measure if there is spasticity present in a person's muscle and its response to movement. It will be measured for Quadriceps, Hamstrings, Gastrocnemius. A large difference between R1 and R2 suggests a large dynamic component with a greater capacity for change or improvement. A small difference between R1 and R2 suggests a predominantly fixed contracture in the muscle with a poorer capacity for change.
Time frame: Week 8
Modified Tardieu Scale
Modified Tardieu Scale is to measure if there is spasticity present in a person's muscle and its response to movement. It will be measured for Quadriceps, Hamstrings, Gastrocnemius. A large difference between R1 and R2 suggests a large dynamic component with a greater capacity for change or improvement. A small difference between R1 and R2 suggests a predominantly fixed contracture in the muscle with a poorer capacity for change.
Time frame: Week 16
Modified Tardieu Scale
Modified Tardieu Scale is to measure if there is spasticity present in a person's muscle and its response to movement. It will be measured for Quadriceps, Hamstrings, Gastrocnemius. A large difference between R1 and R2 suggests a large dynamic component with a greater capacity for change or improvement. A small difference between R1 and R2 suggests a predominantly fixed contracture in the muscle with a poorer capacity for change.
Time frame: Week 20
EQ5D
EQ5D is an instrument which evaluates the generic quality of life developed in Europe and widely used. It has one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each dimension scored from 1 to 5, the higher score indicates worse performance.
Time frame: Week 0
EQ5D
EQ5D is an instrument which evaluates the generic quality of life developed in Europe and widely used. It has one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each dimension scored from 1 to 5, the higher score indicates worse performance.
Time frame: Week 8
EQ5D
EQ5D is an instrument which evaluates the generic quality of life developed in Europe and widely used. It has one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each dimension scored from 1 to 5, the higher score indicates worse performance.
Time frame: Week 16
EQ5D
EQ5D is an instrument which evaluates the generic quality of life developed in Europe and widely used. It has one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each dimension scored from 1 to 5, the higher score indicates worse performance.
Time frame: Week 20
EMG measurement
EMG signals from bilateral Quadriceps, Tibialis Anterior, Gastrocnemius, Rectus Abdominis will be recorded for about 10 seconds. Root-Mean-Square (RMS) of the EMG signals will be calculated.
Time frame: Week 0
EMG measurement
EMG signals from bilateral Biceps, Triceps, Wrist Extensors/Flexors and Finger Extensors/Flexors will be recorded for about 10 seconds. Root-Mean-Square (RMS) of the EMG signals will be calculated.
Time frame: Week 8
EMG measurement
EMG signals from bilateral Biceps, Triceps, Wrist Extensors/Flexors and Finger Extensors/Flexors will be recorded for about 10 seconds. Root-Mean-Square (RMS) of the EMG signals will be calculated.
Time frame: Week 16
EMG measurement
EMG signals from bilateral Biceps, Triceps, Wrist Extensors/Flexors and Finger Extensors/Flexors will be recorded for about 10 seconds. Root-Mean-Square (RMS) of the EMG signals will be calculated.
Time frame: Week 20
Box and Block Assessment
It assesses gross motor dexterity by measuring the number of small blocks the subject can move from one compartment of a box to another within 60 seconds.
Time frame: Week 0
Box and Block Assessment
It assesses gross motor dexterity by measuring the number of small blocks the subject can move from one compartment of a box to another within 60 seconds.
Time frame: Week 8
Box and Block Assessment
It assesses gross motor dexterity by measuring the number of small blocks the subject can move from one compartment of a box to another within 60 seconds.
Time frame: Week 16
Box and Block Assessment
It assesses gross motor dexterity by measuring the number of small blocks the subject can move from one compartment of a box to another within 60 seconds.
Time frame: Week 20
Nine Hole Peg Test
It is a standardized, quantitative assessment used to measure finger dexterity. It is administered by asking the subject to take the pegs from a container, one by one, and place them into holes on the board as quickly as possible. The subject must then remove the pegs from the holes, one by one, and replace them back into the container.
Time frame: Week 0
Nine Hole Peg Test
It is a standardized, quantitative assessment used to measure finger dexterity. It is administered by asking the subject to take the pegs from a container, one by one, and place them into holes on the board as quickly as possible. The subject must then remove the pegs from the holes, one by one, and replace them back into the container.
Time frame: Week 8
Nine Hole Peg Test
It is a standardized, quantitative assessment used to measure finger dexterity. It is administered by asking the subject to take the pegs from a container, one by one, and place them into holes on the board as quickly as possible. The subject must then remove the pegs from the holes, one by one, and replace them back into the container.
Time frame: Week 16
Nine Hole Peg Test
It is a standardized, quantitative assessment used to measure finger dexterity. It is administered by asking the subject to take the pegs from a container, one by one, and place them into holes on the board as quickly as possible. The subject must then remove the pegs from the holes, one by one, and replace them back into the container.
Time frame: Week 20
Spinal Cord Injury Independence Measure (SCIIM)
It is for assessing ADL function. It looks at self-care, respiration and sphincter management, and a patient's mobility abilities. Scores range from 0 (total dependence) to 100 (complete independence).
Time frame: Week 0
Spinal Cord Injury Independence Measure (SCIIM)
It is for assessing ADL function. It looks at self-care, respiration and sphincter management, and a patient's mobility abilities. Scores range from 0 (total dependence) to 100 (complete independence).
Time frame: Week 8
Spinal Cord Injury Independence Measure (SCIIM)
It is for assessing ADL function. It looks at self-care, respiration and sphincter management, and a patient's mobility abilities. Scores range from 0 (total dependence) to 100 (complete independence).
Time frame: Week 16
Spinal Cord Injury Independence Measure (SCIIM)
It is for assessing ADL function. It looks at self-care, respiration and sphincter management, and a patient's mobility abilities. Scores range from 0 (total dependence) to 100 (complete independence).
Time frame: Week 20
Modified Goal attainment Scale (GAS)
It provides a measure of how much of patient identified goals are achieved at the time of assessment.
Time frame: Week 0
Modified Goal attainment Scale (GAS)
It provides a measure of how much of patient identified goals are achieved at the time of assessment.
Time frame: Week 8
Modified Goal attainment Scale (GAS)
It provides a measure of how much of patient identified goals are achieved at the time of assessment.
Time frame: Week 16
Modified Goal attainment Scale (GAS)
It provides a measure of how much of patient identified goals are achieved at the time of assessment.
Time frame: Week 20
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National University Hospital, Singapore